Brief: Cytek Biosciences Q2 Revenue USD 49.693 Million Vs. IBES Estimate USD 45.7 Million
08/08/2023 21:05
Aug 08 (Reuters) - Cytek Biosciences Q2 adjusted EBITDA USD 1.542 million. * Q2 net income USD -4.388 million * Q2 pretax profit USD -6.595 million * outlook FY revenue USD 205-220 million
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million